RIASTAP

This brand name is authorized in Canada, Cyprus, Spain, Finland, France, Ireland, Malta, New Zealand, Poland, United Kingdom, United States

Active ingredients

The drug RIASTAP contains one active pharmaceutical ingredient (API):

1 Human fibrinogen
UNII N94833051K - FIBRINOGEN HUMAN

Human fibrinogen (coagulation factor I), in the presence of thrombin, activated coagulation factor XIII (F XIIIa) and calcium ions is converted into a stable and elastic three-dimensional fibrin haemostatic clot. The administration of human fibrinogen concentrate provides an increase in plasma fibrinogen level and can temporarily correct the coagulation defect of patients with fibrinogen deficiency.

Read about Human fibrinogen

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
RIASTAP Powder for solution for injection or infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
B02BB01 Human fibrinogen B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BB Fibrinogen
Discover more medicines within B02BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02393352
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 72725
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 422474
Country: FR Base de données publique des médicaments Identifier(s): 61179660
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 185608
Country: MT Medicines Authority Identifier(s): MA665/00401
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 18613
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100244762
Country: US FDA, National Drug Code Identifier(s): 63833-891

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.